Orthokeratology for Near-sightedness
(ALWAOM Trial)

Recruiting in Palo Alto (17 mi)

Age: 18 - 65

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Art Optical Contact Lens, Inc.

No Placebo Group

Trial Summary

What is the purpose of this trial?Purpose: To determine axial length progression and its relationship with myopia onset and progression in adults.

Eligibility Criteria

This trial is for first-year optometry students with mild to moderate near-sightedness (+2.00D to -5.00D) and astigmatism up to -1.50D, who are not presbyopic, have never used myopia control treatments like Orthokeratology lenses or specific drugs, and do not have significant eye diseases.

Inclusion Criteria

I am not using any treatments to control nearsightedness.

Refractive error: spherical Component +2.00D to -5.00D; astigmatic Component up to -1.50D; non-presbyopic

1st year optometry student

+1 more

Exclusion Criteria

I am using treatments to control my nearsightedness.

I have a serious eye condition affecting the front or back part of my eye.

Pregnancy

+3 more

Participant Groups

The study aims to understand how the length of the eye changes in adults developing near-sightedness by using a non-surgical treatment called Orthokeratology, which reshapes the cornea temporarily using special contact lenses worn overnight.

1Treatment groups

Experimental Treatment

Group I: OrthokeratologyExperimental Treatment1 Intervention

Orthokeratology is fitting of a contact lens for overnight wear to flatten the cornea and correct myopia temporarily during the day. This procedure has also been shown to slow down the axial length growth in children.